triggering receptor expressed on myeloid cells 2; triggering receptor expressed on monocytes 2 (TREM2)
Jump to navigation
Jump to search
Function
- possible role in chronic inflammatory conditions
- may stimulate production of constitutive rather than inflammatory chemokines & cytokines
- forms a receptor signaling complex with TYROBP (TYRO protein tyrosine kinase binding protein); activating immune responses in macrophages & dendritic cells
- associates with DAP12 for its signaling function
- LILRB2 mediates TREM2 signaling[6]
- RHOH & NCK2 encode signaling molecules downstream from TREM2 that influence cytoskeletal rearrangement of microglia
- has both exogenous ligands on pathogens & endogenous ligands
- Hsp60 is appears to be an agonist of TREM2
- an endogenous ligand may be present on dendritic cells
- activation of TREM2 may stimulate
- proliferation of CD4-positive T-cells
- secretion of TNF & CCL2
- TREM2 may have anti-inflammatory function(s) via inhibition of Toll-like receptor(s)
- TREM2 can inhibit maturation of dendritic cells
- TREM2 can inhibit type I interferon responses
- TREM2 can inhibit induction of antigen-specific T-cell proliferation
Compartment
- isoform 1: cell membrane
- isoforms 2,3: secreted
Alternative splicing
named isoforms=3
Expression
- macrophages
- dendritic cells
- osteoclasts
- NOT found on granulocytes or monocytes
- expressed on myeloid cells in CSF & as soluble TREM2 in CSF[5]
- in the CNS, expressed on microglia
- expressed throughout the CNS, especially in white matter
- strongest expression in the basal ganglia, corpus callosum, medulla oblongata & spinal cord
- expression rises in parallel with expression of beta-amyloid in the cerebral cortex[4]
- TREM2 is overexpressed in subtype 1 (hyperplastic subtype) of Alzheimer's disease[6]
Pathology
- CSF soluble TREM2 & TREM2 expressed on microglia may play a role in facilitation of PHF-tau propagation by activated microglia in association with beta-amyloid[5]
- defects in TREM2 or TYROBP genes associated with presenile dementia with bone cysts
Polymorphism
- TREM2 variant rs75932628 confers a 3-fold increase in risk for Alzheimer's disease[4]
- increased risk attributed to diminished function of TREM2
More general terms
Additional terms
References
- ↑ OMIM https://mirror.omim.org/entry/605086
- ↑ Entrez Gene http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=54209
- ↑ UniProt http://www.uniprot.org/uniprot/Q9NZC2.html
- ↑ 4.0 4.1 4.2 Jonsson T et al Variant of TREM2 Associated with the Risk of Alzheimer's Disease N Engl J Med. November 14, 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23150908 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1211103
Guerreiro R et al TREM2 Variants in Alzheimer's Disease N Engl J Med. November 14, 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23150934 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1211851 - ↑ 5.0 5.1 5.2 Pascoal TA, Benedet AL, Ashton NJ et al. Microglial activation and tau propagate jointly across Braak stages. Nat Med 2021. August 21 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34446931 https://www.nature.com/articles/s41591-021-01456-w
- ↑ 6.0 6.1 6.2 Tims BM, Vromen EM, Mjaavatten O et al Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. Nat Aging. 2024 Jan;4(1):33-47. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38195725 PMCID: PMC10798889 Free PMC article. https://www.nature.com/articles/s43587-023-00550-7